SPDR S&P Biotech ETF $XBI Shares Sold by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 116,119 shares of the exchange traded fund’s stock after selling 4,085 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in SPDR S&P Biotech ETF were worth $14,158,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. China Universal Asset Management Co. Ltd. grew its position in SPDR S&P Biotech ETF by 868.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock worth $493,000 after purchasing an additional 4,411 shares during the period. Ashton Thomas Private Wealth LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $417,000. Banque Pictet & Cie SA grew its holdings in SPDR S&P Biotech ETF by 24.1% during the fourth quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock worth $7,910,000 after acquiring an additional 12,595 shares during the period. Apella Capital LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $490,000. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $1,287,000.

SPDR S&P Biotech ETF Trading Down 2.2%

Shares of NYSEARCA:XBI opened at $133.62 on Tuesday. SPDR S&P Biotech ETF has a 12-month low of $79.49 and a 12-month high of $139.19. The business has a 50 day moving average of $131.22 and a two-hundred day moving average of $126.19. The company has a market capitalization of $8.52 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.